Literature DB >> 15509574

Suppression of wild-type rhodopsin maturation by mutants linked to autosomal dominant retinitis pigmentosa.

Rahul S Rajan1, Ron R Kopito.   

Abstract

Autosomal dominant retinitis pigmentosa (ADRP) has been linked to mutations in the gene encoding rhodopsin. Most RP-linked rhodopsin mutants are unable to fold correctly in the endoplasmic reticulum, are degraded by the ubiquitin proteasome system, and are highly prone to forming detergent-insoluble high molecular weight aggregates. Here we have reported that coexpression of folding-deficient, but not folding-proficient, ADRP-linked rhodopsin mutants impairs delivery of the wild-type protein to the plasma membrane. Fluorescence resonance energy transfer and co-precipitation studies revealed that mutant and wild-type rhodopsins form a high molecular weight, detergent-insoluble complex in which the two proteins are in close (<70 A) proximity. Co-expression of ARDP-linked rhodopsin folding-deficient mutants resulted in enhanced proteasome-mediated degradation and steady-state ubiquitination of the wild-type protein. These data suggested a dominant negative effect on conformational maturation that may underlie the dominant inheritance of ARDP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509574     DOI: 10.1074/jbc.M406448200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  G protein-coupled receptor rhodopsin.

Authors:  Krzysztof Palczewski
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

2.  Opsin is present as dimers in COS1 cells: identification of amino acids at the dimeric interface.

Authors:  Parvathi Kota; Philip J Reeves; Uttam L Rajbhandary; H Gobind Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

3.  Autosomal recessive retinitis pigmentosa and E150K mutation in the opsin gene.

Authors:  Li Zhu; Yoshikazu Imanishi; Sławomir Filipek; Andrei Alekseev; Beata Jastrzebska; Wenyu Sun; David A Saperstein; Krzysztof Palczewski
Journal:  J Biol Chem       Date:  2006-05-31       Impact factor: 5.157

4.  Glycosylation of rhodopsin is necessary for its stability and incorporation into photoreceptor outer segment discs.

Authors:  Anne R Murray; Linda Vuong; Daniel Brobst; Steven J Fliesler; Neal S Peachey; Marina S Gorbatyuk; Muna I Naash; Muayyad R Al-Ubaidi
Journal:  Hum Mol Genet       Date:  2015-01-30       Impact factor: 6.150

5.  Curvature and hydrophobic forces drive oligomerization and modulate activity of rhodopsin in membranes.

Authors:  Ana Vitória Botelho; Thomas Huber; Thomas P Sakmar; Michael F Brown
Journal:  Biophys J       Date:  2006-09-29       Impact factor: 4.033

Review 6.  Chaperoning G protein-coupled receptors: from cell biology to therapeutics.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Endocr Rev       Date:  2014-03-24       Impact factor: 19.871

7.  Assessment of visual function and retinal structure following acute light exposure in the light sensitive T4R rhodopsin mutant dog.

Authors:  Simone Iwabe; Gui-Shuang Ying; Gustavo D Aguirre; William A Beltran
Journal:  Exp Eye Res       Date:  2016-04-13       Impact factor: 3.467

8.  Quaternary structures of opsin in live cells revealed by FRET spectrometry.

Authors:  Ashish K Mishra; Megan Gragg; Michael R Stoneman; Gabriel Biener; Julie A Oliver; Przemyslaw Miszta; Slawomir Filipek; Valerică Raicu; Paul S-H Park
Journal:  Biochem J       Date:  2016-09-13       Impact factor: 3.857

9.  Inactivation of VCP/ter94 suppresses retinal pathology caused by misfolded rhodopsin in Drosophila.

Authors:  Ana Griciuc; Liviu Aron; Michel J Roux; Rüdiger Klein; Angela Giangrande; Marius Ueffing
Journal:  PLoS Genet       Date:  2010-08-26       Impact factor: 5.917

Review 10.  Rhodopsin: the functional significance of asn-linked glycosylation and other post-translational modifications.

Authors:  Anne R Murray; Steven J Fliesler; Muayyad R Al-Ubaidi
Journal:  Ophthalmic Genet       Date:  2009-09       Impact factor: 1.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.